QGQun Guan

Qun Guan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Qun Guan has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • Yu-Bin Dong

    College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education

    31 shared publications
  • Yan-An Li

    College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan 250014, P. R. China

    17 shared publications
  • Le-Le Zhou

    University of Macau

    16 shared publications
  • Wen-Yan Li

    College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan 250014, P. R. China

    11 shared publications
  • Le‐Le Zhou

    State Key Laboratory of Mechanism and Quality of Chinese Medicine Institute of Chinese Medical Sciences University of Macau Taipa Macao China

    8 shared publications
  • Jing-Lan Kan

    College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging in Universities of Shandong, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan, 250014, P. R. China

    6 shared publications

Latest Publications

  • Open Access

    Spontaneous Intracellular Formation of Covalent Organic Frameworks via Enzyme-Initiated Cascade Reactions to Boost Cancer Radiotherapy

    by Qun Guan, Le-Le Zhou, Wei Zhou, Zhiqing Yang, Bichun Chen, Yan-An Li, Ruibing Wang

    Tumor radioresistance is a leading cause of radiotherapy failure. This study presents a facile strategy for enhancing tumor radiosensitivity using a covalent organic framework (COF) constructed within cells. Upon cellular internalization, acetamide and iodoacetal precursors undergo hydrolysis to form amine and iodoaldehyde monomers that spontaneously polymerize and crystallize within the lysosomes. This intracellularly generated iodine-rich COF (in situ UM-113) possesses an ordered structure that effectively facilitates radiation energy deposition, producing localized reactive oxygen species and amplifying DNA damage. In vitro and in vivo, in situ UM-113 suppresses tumor growth by triggering both ferroptosis and mitotic catastrophe. This strategy bypasses the complex synthesis and purification steps required for conventional nanomedicine. Thus, in situ COF construction is a promising strategy for enhancing cancer radiotherapy, offering a modular platform for the intracellular synthesis of functional bionanomaterials.

  • Open Access

    In Situ Synthesis of Covalent Organic Frameworks Inside Cells for Triggering Ferroptosis and Immunotherapy

    by Qun Guan, Le‐Le Zhou, Zhiqing Yang, Yan‐An Li, Leyong Wang, Ruibing Wang

    The synthesis of non‐natural polymers inside living systems has become an effective approach for controlling cellular functions and behaviors. However, in situ synthesis of crystalline polymers, such as covalent organic frameworks (COFs), inside cells using dynamic covalent chemistry faces challenges in aqueous environments, crystallization, and functionality. Herein, we present an intralysosomal crystalline polymerization strategy to synthesize COFs inside tumor cells through an acid‐catalyzed imine condensation reaction. The COFs synthesized intracellularly exhibit inherent fluorescence and well‐defined crystalline structures, allowing real‐time monitoring of the synthesis and product characterization. The formation of imine frameworks inside cell lysosomes induces lysosomal damage, activates lysosomal iron, and triggers immunogenic ferroptosis, thus enhancing antitumor immunotherapy. This strategy of intralysosomal crystalline polymerization facilitates the ambient synthesis of COFs, opening avenues for therapeutic polymerization reactions and providing insights into cellular responses to in situ polymer synthesis.


  • Open Access

    An sp2 Carbon‐Conjugated Covalent Organic Framework for Fusing Lipid Droplets and Engineered Macrophage Therapy

    by Qun Guan, Le‐Le Zhou, Zhiqing Yang, Beibei Xie, Yan‐An Li, Ruibing Wang

    Engineered immune cell therapy has proven to be a transformative cancer treatment despite the challenges of its prohibitive costs and manufacturing complexity. In this study, we propose a concise “lipid droplet fusion” strategy for engineering macrophages. Because of the integration of hydrophobic alkyl chains and π‐conjugated structures, the mildly synthesized sp2C‐conjugated covalent organic framework (COF) UM‐101 induced lipid droplet fusion and metabolic reprogramming of macrophages, thus promoting their antitumor classical activation. Intravenous injection of UM‐101–engineered macrophages effectively inhibited tumor progression. These results represent the first report of room‐temperature synthesis of sp2C‐conjugated COFs for engineered immune cell therapy, providing a new perspective for the development of therapeutic immune cells via organelle manipulation.


  • Open Access

    An sp2 Carbon‐Conjugated Covalent Organic Framework for Fusing Lipid Droplets and Engineered Macrophage Therapy

    by Qun Guan, Le‐Le Zhou, Zhiqing Yang, Beibei Xie, Yan‐An Li, Ruibing Wang

    Engineered immune cell therapy has proven to be a transformative cancer treatment despite the challenges of its prohibitive costs and manufacturing complexity. In this study, we propose a concise “lipid droplet fusion” strategy for engineering macrophages. Because of the integration of hydrophobic alkyl chains and π‐conjugated structures, the mildly synthesized sp2C‐conjugated covalent organic framework (COF) UM‐101 induced lipid droplet fusion and metabolic reprogramming of macrophages, thus promoting their antitumor classical activation. Intravenous injection of UM‐101–engineered macrophages effectively inhibited tumor progression. These results represent the first report of room‐temperature synthesis of sp2C‐conjugated COFs for engineered immune cell therapy, providing a new perspective for the development of therapeutic immune cells via organelle manipulation.


  • MOF-based nanoagent for self-illuminating photodynamic therapy

    by Jing-Lan Kan, Fan-Hong Lv, Wen-Xiu Ren, Qun Guan, Anqi Xue, Jie Feng, Yu-Bin Dong

    A MOF-based self-illuminating system, which can be a highly efficient photodynamic therapy nanoagent for tumor treatment without an external light source, is reported.


  • Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy

    by Le‐Le Zhou, Qun Guan, Yu‐Bin Dong

    Nanomedicines are extensively used in cancer therapy. Covalent organic frameworks (COFs) are crystalline organic porous materials with several benefits for cancer therapy, including porosity, design flexibility, functionalizability, and biocompatibility. This review examines the use of COFs in cancer therapy from the perspective of reticular chemistry and function‐oriented materials design. First, the modification sites and functionalization methods of COFs are discussed, followed by their potential as multifunctional nanoplatforms for tumor targeting, imaging, and therapy by integrating functional components. Finally, some challenges in the clinical translation of COFs are presented with the hope of promoting the development of COF‐based anticancer nanomedicines and bringing COFs closer to clinical trials.


  • Covalent Organic Frameworks: Opportunities for Rational Materials Design in Cancer Therapy

    by Le‐Le Zhou, Qun Guan, Yu‐Bin Dong

    Nanomedicines are extensively used in cancer therapy. Covalent organic frameworks (COFs) are crystalline organic porous materials with several benefits for cancer therapy, including porosity, design flexibility, functionalizability, and biocompatibility. This review examines the use of COFs in cancer therapy from the perspective of reticular chemistry and function‐oriented materials design. First, the modification sites and functionalization methods of COFs are discussed, followed by their potential as multifunctional nanoplatforms for tumor targeting, imaging, and therapy by integrating functional components. Finally, some challenges in the clinical translation of COFs are presented with the hope of promoting the development of COF‐based anticancer nanomedicines and bringing COFs closer to clinical trials.


  • A Multifunctional Covalent Organic Framework Nanozyme for Promoting Ferroptotic Radiotherapy against Esophageal Cancer

    by Le-Le Zhou, Qun Guan, Wei Zhou, Jing-Lan Kan, Kai Teng, Man Hu, Yu-Bin Dong

    Radiotherapy is inevitably accompanied by some degree of radiation resistance, which leads to local recurrence and even therapeutic failure. To overcome this limitation, herein, we report the room-temperature synthesis of an iodine- and ferrocene-loaded covalent organic framework (COF) nanozyme, termed TADI-COF-Fc, for the enhancement of radiotherapeutic efficacy in the treatment of radioresistant esophageal cancer. The iodine atoms on the COF framework not only exerted a direct effect on radiotherapy, increasing its efficacy by increasing X-ray absorption, but also promoted the radiolysis of water, which increased the production of reactive oxygen species (ROS). In addition, the ferrocene surface decoration disrupted redox homeostasis by increasing the levels of hydroxyl and lipid peroxide radicals and depleting intracellular antioxidants. Both in vitro and in vivo experiments substantiated the excellent radiotherapeutic response of TADI-COF-Fc. This study demonstrates the potential of COF-based multinanozymes as radiosensitizers and suggests a possible treatment integration strategy for combination oncotherapy.


  • A covalent organic framework-based nanoreactor for enhanced photothermal therapy via inhibiting intracellular heat defense systems

    by Yan-An Li, Jing-Jing Wan, Wen-Yan Li, Qun Guan, Yu-Bin Dong

    Herein, we report an indocyanine green (ICG)-decorated and glucose oxidase (GOx)-loaded nanoscale composite COF material via a stepwise post-synthetic modification. The obtained GOx@COF-ICG can achieve synergistic inhibition of intracellular heat defense systems through starvation therapy to enhance photothermal therapy of tumors.


  • A reactive oxygen species-responsive covalent organic framework for tumor combination therapy

    by Wen-Yan Li, Jing-Lan Kan, Jing-Jing Wan, Yan-An Li, Tian Song, Bo Wang, Qun Guan, Le-Le Zhou, Yu-Bin Dong

    Herein, we report the first reactive oxygen species (ROS)-responsive dithioketal-linked covalent organic framework (COF) for synergetic chemotherapy and photodynamic therapy (PDT) of cancer. The singlet oxygen (1O2)-responsive COF dissociation and DC_AC50 drug release complement and reinforce each other to allow an efficient combination of PDT and chemotherapy.